ZINADOX-750 TABLET

Product Description

ZINADOX-750 TABLET (PYRAZINAMIDE 750MG)ZINADOX-750 Tablet contains Pyrazinamide 750mg, a frontline antitubercular agent used in combination therapy for the treatment of tuberculosis (TB). It plays a crucial role in shortening TB treatment duration by targeting semi-dormant bacilli residing in acidic environments. Key Benefits: Potent bactericidal activity against Mycobacterium tuberculosis Essential component of first-line TB treatment regimens Helps prevent development of drug resistance when used in combination WHO-recommended active pharmaceutical ingredient (API) Usage/Application: ZINADOX-750 is prescribed as part of Directly Observed Treatment Short-course (DOTS) and is widely used in government and private TB eradication programs. It is typically administered under medical supervision during the intensive phase of TB treatment. Industry Use: Ideal for hospitals, clinics, government supply contracts, pharmaceutical wholesalers, and global health NGOs. Available for bulk procurement and third-party manufacturing with quality compliance.